Publicou 6 edições por ano
ISSN Imprimir: 1045-4403
ISSN On-line: 2162-6502
Indexed in
P2 Receptors in Bone—Modulation of Osteoclast Formation and Activity via P2X7 Activation
RESUMO
The concept that adenosine triphosphate (ATP) can act as an extracellular signaling molecule via interactions with specific purinergic receptors to mediate a wide variety of processes as diverse as neurotransmission (Edwards et al., 1992), inflammation (Perregaux et al., 1994), apoptosis (Chow et al., 1997), and bone remodelling (Jones et al., 1997; Morrison et al., 1998) is now widely accepted. Since the early work of Burnstock (Burnstock, 1972), the number of characterized P2 receptors responsive to extracellular nucleotides has increased dramatically. It is now known that both osteoblasts and osteoclasts express multiple P2 receptor subtypes, and the increasing number of nucleotide-induced effects reported to occur in bone serves to highlight the importance of these receptors in the bone microenvironment and the bone remodeling processes. In this article we will review work from our laboratory, and others, that has established nucleotides and P2 receptors as important signaling molecules in bone. In particular, we will focus on the expression of P2 receptors by osteoclasts and, more specifically, the P2X7 receptor and its paradoxical role in osteoclast function.
-
Shieh Char-Chang, Jarvis Michael F, Lee Chih-Hung, Perner Richard J, P2X receptor ligands and pain, Expert Opinion on Therapeutic Patents, 16, 8, 2006. Crossref
-
Penolazzi Letizia, Bianchini Ercolina, Lambertini Elisabetta, Baraldi Pier Giovanni, Romagnoli Romeo, Piva Roberta, Gambari Roberto, N-Arylpiperazine modified analogues of the P2X7 receptor KN-62 antagonist are potent inducers of apoptosis of human primary osteoclasts, Journal of Biomedical Science, 12, 6, 2005. Crossref
-
Gartland Alison, Gallagher James, Buckley Katherine, The Role of Purinergic Signaling in the Interactions between Skeletal Cells, in Nucleotides and Regulation of Bone Cell Function, 2006. Crossref
-
Bours M.J.L., Swennen E.L.R., Di Virgilio F., Cronstein B.N., Dagnelie P.C., Adenosine 5′-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation, Pharmacology & Therapeutics, 112, 2, 2006. Crossref
-
Burnstock Geoffrey, Arnett Tim, Future Directions, in Nucleotides and Regulation of Bone Cell Function, 2006. Crossref
-
Korcok Jasminka, Jeffrey Dixon S, Sims Stephen, P2 Nucleotide Receptor Signaling in Osteoclasts, in Nucleotides and Regulation of Bone Cell Function, 2006. Crossref
-
Hansen Rikke Rie, Nielsen Christian K., Nasser Arafat, Thomsen Stine I.M., Eghorn Laura F., Pham Yen, Schulenburg Cecilia, Syberg Susanne, Ding Ming, Stojilkovic Stanko S., Jorgensen Niklas R., Heegaard Anne-Marie, P2X7 receptor-deficient mice are susceptible to bone cancer pain, Pain, 152, 8, 2011. Crossref
-
Syberg Susanne, Petersen Solveig, Beck Jensen Jens-Erik, Gartland Alison, Teilmann Jenni, Chessell Iain, Steinberg Thomas H., Schwarz Peter, Jørgensen Niklas Rye, Genetic Background Strongly Influences the Bone Phenotype of P2X7 Receptor Knockout Mice, Journal of Osteoporosis, 2012, 2012. Crossref
-
Orriss Isabel R., Key Michelle L., Brandao-Burch Andrea, Patel Jessal J., Burnstock Geoffrey, Arnett Timothy R., The regulation of osteoblast function and bone mineralisation by extracellular nucleotides: The role of p2x receptors, Bone, 51, 3, 2012. Crossref
-
Adinolfi Elena, Amoroso Francesca, Giuliani Anna Lisa, P2X7 Receptor Function in Bone-Related Cancer, Journal of Osteoporosis, 2012, 2012. Crossref
-
Husted L. B., Harsløf T., Stenkjær L., Carstens M., Jørgensen N. R., Langdahl B. L., Functional polymorphisms in the P2X7 receptor gene are associated with osteoporosis, Osteoporosis International, 24, 3, 2013. Crossref
-
Civitelli Roberto, Stains Joseph P., Soo Shin Chan, Jørgensen Niklas R., Intercellular Junctions and Cell–Cell Communication in the Skeletal System, in Principles of Bone Biology, 2008. Crossref
-
Syberg Susanne, Brandao-Burch Andrea, Patel Jessal J, Hajjawi Mark, Arnett Timothy R, Schwarz Peter, Jorgensen Niklas R, Orriss Isabel R, Clopidogrel (Plavix), a P2Y12receptor antagonist, inhibits bone cell function in vitro and decreases trabecular bone in vivo, Journal of Bone and Mineral Research, 27, 11, 2012. Crossref
-
Syberg Susanne, Schwarz Peter, Petersen Solveig, Steinberg Thomas H., Jensen Jens-Erik Beck, Teilmann Jenni, Jørgensen Niklas Rye, Association between P2X7 Receptor Polymorphisms and Bone Status in Mice, Journal of Osteoporosis, 2012, 2012. Crossref
-
Kaczmarek-Hájek Karina, Lörinczi Éva, Hausmann Ralf, Nicke Annette, Molecular and functional properties of P2X receptors—recent progress and persisting challenges, Purinergic Signalling, 8, 3, 2012. Crossref
-
Burnstock Geoffrey, Arnett Timothy R., Orriss Isabel R., Purinergic signalling in the musculoskeletal system, Purinergic Signalling, 9, 4, 2013. Crossref
-
Ayala-Peña Victoria B., Scolaro Luis A., Santillán Graciela E., ATP and UTP stimulate bone morphogenetic protein-2,-4 and -5 gene expression and mineralization by rat primary osteoblasts involving PI3K/AKT pathway, Experimental Cell Research, 319, 13, 2013. Crossref
-
He Wenjie, Wilder Tuere, Cronstein Bruce N, Rolofylline, an adenosine A1receptor antagonist, inhibits osteoclast differentiation as an inverse agonist, British Journal of Pharmacology, 170, 6, 2013. Crossref
-
Wang Ning, Gartland Alison, Role of the P2X7 receptor in the osteogenic differentiation of mesenchymal cells and in osteoclast fusion, Purinergic Signalling, 9, 3, 2013. Crossref
-
Kvist Torben Madsen, Schwarz Peter, Jørgensen Niklas Rye, The P2X7 Receptor: A Key Player in Immune-Mediated Bone Loss?, The Scientific World Journal, 2014, 2014. Crossref
-
Kariya Taro, Tanabe Natsuko, Shionome Chieko, Manaka Soichiro, Kawato Takayuki, Zhao Ning, Maeno Masao, Suzuki Naoto, Shimizu Noriyoshi, Tension Force‐Induced ATP Promotes Osteogenesis Through P2X7 Receptor in Osteoblasts, Journal of Cellular Biochemistry, 116, 1, 2015. Crossref
-
Agrawal Ankita, Gartland Alison, P2X7 receptors: role in bone cell formation and function, Journal of Molecular Endocrinology, 54, 2, 2015. Crossref
-
Orriss Isabel R., The role of purinergic signalling in the musculoskeletal system, Autonomic Neuroscience, 191, 2015. Crossref
-
Kvist T.M., Syberg S., Petersen S., Ding M., Jørgensen N.R., Schwarz P., The role of the P2X7 receptor on bone loss in a mouse model of inflammation-mediated osteoporosis, Bone Reports, 7, 2017. Crossref
-
De Marchi Elena, Orioli Elisa, Dal Ben Diego, Adinolfi Elena, P2X7 Receptor as a Therapeutic Target, in Ion channels as therapeutic targets, part B, 104, 2016. Crossref
-
Varley Ian, Greeves Julie P., Sale Craig, Friedman Eitan, Moran Daniel S., Yanovich Ran, Wilson Peter J., Gartland Alison, Hughes David C., Stellingwerff Trent, Ranson Craig, Fraser William D., Gallagher James A., Functional polymorphisms in the P2X7 receptor gene are associated with stress fracture injury, Purinergic Signalling, 12, 1, 2016. Crossref
-
Giuliani Anna Lisa, Colognesi Davide, Ricco Tiziana, Roncato Carlotta, Capece Marina, Amoroso Francesca, Wang Qi Guang, De Marchi Elena, Gartland Allison, Di Virgilio Francesco, Adinolfi Elena, Kanellopoulos Jean, Trophic Activity of Human P2X7 Receptor Isoforms A and B in Osteosarcoma, PLoS ONE, 9, 9, 2014. Crossref
-
Lemaire Irma, Falzoni Simonetta, Zhang Bin, Pellegatti Patrizia, Di Virgilio Francesco, The P2X7Receptor and Pannexin-1 Are Both Required for the Promotion of Multinucleated Macrophages by the Inflammatory Cytokine GM-CSF, The Journal of Immunology, 187, 7, 2011. Crossref
-
Bartlett Rachael, Stokes Leanne, Sluyter Ronald, Sibley David R., The P2X7 Receptor Channel: Recent Developments and the Use of P2X7 Antagonists in Models of Disease, Pharmacological Reviews, 66, 3, 2014. Crossref
-
Kim Hyunsoo, Walsh Matthew C., Yu Jiyeon, Laskoski Paul, Takigawa Kei, Takegahara Noriko, Choi Yongwon, Methylosome protein 50 associates with the purinergic receptor P2X5 and is involved in osteoclast maturation, FEBS Letters, 594, 1, 2020. Crossref
-
Pellegatti Patrizia, Falzoni Simonetta, Donvito Giovanna, Lemaire Irma, Di Virgilio Francesco, P2X7 receptor drives osteoclast fusion by increasing the extracellular adenosine concentration, The FASEB Journal, 25, 4, 2011. Crossref
-
Stokes Leanne, Bidula Stefan, Bibič Lučka, Allum Elizabeth, To Inhibit or Enhance? Is There a Benefit to Positive Allosteric Modulation of P2X Receptors?, Frontiers in Pharmacology, 11, 2020. Crossref
-
Surprenant Annmarie, North R. Alan, Signaling at Purinergic P2X Receptors, Annual Review of Physiology, 71, 1, 2009. Crossref
-
Steinberg Thomas H., Hiken Jeffrey F., P2 receptors in macrophage fusion and osteoclast formation, Purinergic Signalling, 3, 1-2, 2007. Crossref
-
Zeng Dehui, Yao Pingbo, Zhao Hong, P2X7, a critical regulator and potential target for bone and joint diseases, Journal of Cellular Physiology, 234, 3, 2019. Crossref